SLC7A5 and neoplasm: SLC7A5, required for tumour growth in many settings38, showed no proliferation defect in CRISPRi screens in RPMI but a strong defect in a medium low in His, Ile, Leu, Met, Phe, Trp, Tyr or Val (Fig. 2e).